Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Harold L Atkins

Showing results (11-20 of 42) with videos related to

Pageof 5
Sort By:
The Canadian Journal of Neurological Sciences. Le Journal Canadien Des Sciences Neurologiques|September 13, 2019
Does Resetting the Immune System Fix Multiple Sclerosis?Gauruv Bose, Simon D X Thebault, Harold L Atkins, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|January 10, 2012
Autologous hematopoietic stem cell transplantation for autoimmune disease--is it now ready for prime time?Harold L Atkins, Paolo A Muraro, Jacob M van Laar, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|May 5, 2020
Autologous hematopoietic stem cell transplantation for multiple sclerosis: A current perspectiveGauruv Bose, Simon Thebault, Carolina A Rush, et al.
Journal of the Neurological Sciences|November 6, 2013
Cognitive fatigue in individuals with multiple sclerosis undergoing immunoablative therapy and hematopoietic stem cell transplantationJason A Berard, Marjorie Bowman, Harold L Atkins, et al.
Annals of Neurology|February 8, 2008
Magnetization transfer ratio evolution with demyelination and remyelination in multiple sclerosis lesionsJacqueline T Chen, D Louis Collins, Harold L Atkins, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|December 15, 2016
One Size Fits All?: Ethical Considerations for Examining Efficacy in First-in-Human Pluripotent Stem Cell StudiesMichelle Gjl Habets, Johannes Jm van Delden, Sophie L Niemansburg, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|June 2, 2016
Brain atrophy after bone marrow transplantation for treatment of multiple sclerosisHyunwoo Lee, Sridar Narayanan, Robert A Brown, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|June 16, 2017
Impact of immunoablation and autologous hematopoietic stem cell transplantation on gray and white matter atrophy in multiple sclerosisHyunwoo Lee, Kunio Nakamura, Sridar Narayanan, et al.
International Journal of Radiation Oncology, Biology, Physics|June 28, 2003
Increased plasma levels of matrix metalloproteinase-9 and tissue inhibitor of metalloproteinase-1 in lung and breast cancer are altered during chest radiotherapyHerbert Susskind, Michelle H Hymowitz, Yat Hong Lau, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|July 21, 2007
A 15-year analysis of early and late autologous hematopoietic stem cell transplant in relapsed, aggressive, transformed, and nontransformed follicular lymphomaMitchell Sabloff, Harold L Atkins, Isabelle Bence-Bruckler, et al.
Pageof 5

Showing results (11-20 of 42) with videos related to

Sort By:
Pageof 5
The Canadian Journal of Neurological Sciences. Le Journal Canadien Des Sciences Neurologiques|September 13, 2019
Does Resetting the Immune System Fix Multiple Sclerosis?Gauruv Bose, Simon D X Thebault, Harold L Atkins, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|January 10, 2012
Autologous hematopoietic stem cell transplantation for autoimmune disease--is it now ready for prime time?Harold L Atkins, Paolo A Muraro, Jacob M van Laar, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|May 5, 2020
Autologous hematopoietic stem cell transplantation for multiple sclerosis: A current perspectiveGauruv Bose, Simon Thebault, Carolina A Rush, et al.
Journal of the Neurological Sciences|November 6, 2013
Cognitive fatigue in individuals with multiple sclerosis undergoing immunoablative therapy and hematopoietic stem cell transplantationJason A Berard, Marjorie Bowman, Harold L Atkins, et al.
Annals of Neurology|February 8, 2008
Magnetization transfer ratio evolution with demyelination and remyelination in multiple sclerosis lesionsJacqueline T Chen, D Louis Collins, Harold L Atkins, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|December 15, 2016
One Size Fits All?: Ethical Considerations for Examining Efficacy in First-in-Human Pluripotent Stem Cell StudiesMichelle Gjl Habets, Johannes Jm van Delden, Sophie L Niemansburg, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|June 2, 2016
Brain atrophy after bone marrow transplantation for treatment of multiple sclerosisHyunwoo Lee, Sridar Narayanan, Robert A Brown, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|June 16, 2017
Impact of immunoablation and autologous hematopoietic stem cell transplantation on gray and white matter atrophy in multiple sclerosisHyunwoo Lee, Kunio Nakamura, Sridar Narayanan, et al.
International Journal of Radiation Oncology, Biology, Physics|June 28, 2003
Increased plasma levels of matrix metalloproteinase-9 and tissue inhibitor of metalloproteinase-1 in lung and breast cancer are altered during chest radiotherapyHerbert Susskind, Michelle H Hymowitz, Yat Hong Lau, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|July 21, 2007
A 15-year analysis of early and late autologous hematopoietic stem cell transplant in relapsed, aggressive, transformed, and nontransformed follicular lymphomaMitchell Sabloff, Harold L Atkins, Isabelle Bence-Bruckler, et al.
Pageof 5